Animal Wound Care Market Size, Growth, Trends | Report 2023-2032
The global animal wound care market was surpassed at USD 1.14 billion in 2022 and is expected to hit around USD 2.23 billion by 2032, growing at a CAGR of 6.92% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 1.14 billion |
| Revenue Forecast by 2032 | USD 2.23 billion |
| Growth rate from 2023 to 2032 | CAGR of 6.92% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Medtronic; 3M; B. Braun Melsungen AG; Virbac; Johnson & Johnson (Ethicon); Advancis Veterinary Ltd.; Innovacyn, Inc.; Vernacare (Robinson Healthcare); NEOGEN Corp.; KeriCure, Inc. |
The market is primarily driven by factors, such as the rising adoption of companion animals, increasing demand for veterinary surgeries, and growing animal injury cases. For instance, according to the U.S. Department of Transportation, over 1 million animals die each year due to road accidents, with several million animals getting injured. Moreover, the increasing number of veterinary visits and rising adoption of pet insurance are boosting industry growth.
Trupanion, a pet insurance company, observed 1.3 million pet insurance enrollments as of June 2022. It observed 32% growth in the second quarter of 2021. The COVID-19 pandemic affected millions of people and businesses around the world. It financially impacted as well as put other implications on most of the veterinary fields, including the animal wound care market. The postponement and cancellation of elective surgeries in animals due to nationwide lockdowns resulted in a decline in postoperative wound cases, thus impacting the industry's growth. Furthermore, on March 2020, the Federation of Veterinarians of Europe (FVE) stated that many small- and medium-sized veterinary businesses were facing a period of financial difficulty in the initial stage of the pandemic.
It also reported that the revenue for veterinary healthcare declined by 50% in various European countries. However, the industry growth has shown a quick recovery during the last quarter of 2020 and from 2021, owing to the resumption of veterinary clinic admissions and the easing of COVID-19 restrictions. Increasing demand for animal protein and advancement in livestock wound care products are other factors boosting the industry growth. For instance, Santa Cruz Animal Health offers a wide range of bovine supplies, such as topical hydrogel and other advanced wound care products for cattle.
On the other hand, animals, such as dogs, are often likely to get injured with minor or serious wounds. One of the common injury cases reported among dogs is trauma caused by accidents. Road accidents are a frequent cause of major trauma, such as bone fractures, internal & external injuries, bleeding & organ trauma, joint dislocations, head trauma, and skin wounds, such as rashes. Animals get injured in various scenarios, which can be severe and require immediate veterinary wound care for stitches, infection prevention, etc. On account of the increasing pet adoption and animal population globally, the industry will have significant growth.
Market Segmentation
By Product
By Animal Type
By End-use
By Distribution Channel
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Animal Wound Care Market
5.1. COVID-19 Landscape: Animal Wound Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Animal Wound Care Market, By Product
8.1. Animal Wound Care Market, by Product, 2023-2032
8.1.1. Surgical Wound Care Products
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Advanced Wound Care Products
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Traditional Wound Care Products
8.1.3.1. Market Revenue and Forecast (2019-2032)
8.1.4. Therapy Devices
8.1.4.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Animal Wound Care Market, By Animal Type
9.1. Animal Wound Care Market, by Animal Type, 2023-2032
9.1.1. Companion Animals
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Livestock Animals
9.1.2.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Animal Wound Care Market, By End-use
10.1. Animal Wound Care Market, by End-use, 2023-2032
10.1.1. Veterinary Hospitals/Clinics
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Homecare
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Research Institutes
10.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Animal Wound Care Market, By Distribution Channel
11.1. Animal Wound Care Market, by Distribution Channel, 2023-2032
11.1.1. Retail
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. E-commerce
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. Veterinary Hospitals/Clinics
11.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global Animal Wound Care Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.1.3. Market Revenue and Forecast, by End-use (2019-2032)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.5.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.1.6.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.1.6.3. Market Revenue and Forecast, by End-use (2019-2032)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.3. Market Revenue and Forecast, by End-use (2019-2032)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.5.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.6.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.7.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.2.8.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.2.8.3. Market Revenue and Forecast, by End-use (2019-2032)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.3.3. Market Revenue and Forecast, by End-use (2019-2032)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.5.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.6.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.7.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.3.8.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.3.8.3. Market Revenue and Forecast, by End-use (2019-2032)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.4.3. Market Revenue and Forecast, by End-use (2019-2032)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.5.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.6.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.7.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2032)
12.4.8.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.4.8.3. Market Revenue and Forecast, by End-use (2019-2032)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.5.3. Market Revenue and Forecast, by End-use (2019-2032)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.5.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2032)
12.5.6.2. Market Revenue and Forecast, by Animal Type (2019-2032)
12.5.6.3. Market Revenue and Forecast, by End-use (2019-2032)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2019-2032)
Chapter 13. Company Profiles
13.1. Medtronic
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. 3M
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. B. Braun Melsungen AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Virbac
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Johnson & Johnson (Ethicon)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Advancis Veterinary Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Innovacyn, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Vernacare (Robinson Healthcare)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. NEOGEN Corp.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. KeriCure, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers